来源:[1] 强生 vs. 艾伯维:哪家医疗巨头更有优势? (https://finance.yahoo.com/news/j-j-vs-abbvie- ...)[2] 生物类似药侵蚀Stelara之际,强生凭借150亿美元创新药季度销售额展现实力 | Fierce Pharma (https://www.fiercepharma.com/pharma/jj-flexes ...)[3] 艾伯维(ABBV)延长Rinvoq专利保护,提振股价 - GuruFocus (https://vertexaisearch.cloud.google.com/groun ...)